カテゴリー： QYResearch, 世界

世界のびまん性大細胞型B細胞リンパ腫薬市場 2019年

【英語タイトル】Global Diffuse Large B Cell Lymphoma Drug Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X06476）・商品コード：DATA909X06476
・発行会社（調査会社）：QYResearch
・発行日：2019年11月15日（※2024年版があります。お問い合わせください）
・ページ数：115
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、びまん性大細胞型B細胞リンパ腫薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、リツキサン、シクロホスファミド、ドキソルビシン、ビンクリスチン、プレドニゾンに、用途別には、病院、診療所、その他にセグメント区分し、びまん性大細胞型B細胞リンパ腫薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・びまん性大細胞型B細胞リンパ腫薬の世界市場概要
・びまん性大細胞型B細胞リンパ腫薬の製造コスト構成分析
・びまん性大細胞型B細胞リンパ腫薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・びまん性大細胞型B細胞リンパ腫薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・びまん性大細胞型B細胞リンパ腫薬のセグメント分析（種類別）
（リツキサン、シクロホスファミド、ドキソルビシン、ビンクリスチン、プレドニゾン）
・びまん性大細胞型B細胞リンパ腫薬のセグメント分析（用途別）
（病院、診療所、その他）
・びまん性大細胞型B細胞リンパ腫薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（AbbVie、Arrien Pharmaceuticals、Aptose Biosciences、BeiGene、Celltrion、CTI BioPharma、Erytech Pharma、Hetero Drugs、Karyopharm Therapeutics、mAbxience、PIQUR Therapeutics、Philogen S.p.A.、Roche、Seattle Genetics、TG Therapeutics、）
・びまん性大細胞型B細胞リンパ腫薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Diffuse Large B Cell Lymphoma Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Diffuse Large B Cell Lymphoma Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Diffuse Large B Cell Lymphoma Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Diffuse Large B Cell Lymphoma Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Diffuse Large B Cell Lymphoma Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
AbbVie
Arrien Pharmaceuticals
Aptose Biosciences
BeiGene
Celltrion
CTI BioPharma
Erytech Pharma
Hetero Drugs
Karyopharm Therapeutics
mAbxience
PIQUR Therapeutics
Philogen S.p.A.
Roche
Seattle Genetics
TG Therapeutics

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Rituxan
Cyclophosphamide
Doxorubicin
Vincristine
Prednisone

Segment by Application
Hospital
Clinic
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Diffuse Large B Cell Lymphoma Drug
1.1 Definition of Diffuse Large B Cell Lymphoma Drug
1.2 Diffuse Large B Cell Lymphoma Drug Segment by Type
1.2.1 Global Diffuse Large B Cell Lymphoma Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Rituxan
1.2.3 Cyclophosphamide
1.2.4 Doxorubicin
1.2.5 Vincristine
1.2.6 Prednisone
1.3 Diffuse Large B Cell Lymphoma Drug Segment by Applications
1.3.1 Global Diffuse Large B Cell Lymphoma Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Diffuse Large B Cell Lymphoma Drug Overall Market
1.4.1 Global Diffuse Large B Cell Lymphoma Drug Revenue (2014-2025)
1.4.2 Global Diffuse Large B Cell Lymphoma Drug Production (2014-2025)
1.4.3 North America Diffuse Large B Cell Lymphoma Drug Status and Prospect (2014-2025)
1.4.4 Europe Diffuse Large B Cell Lymphoma Drug Status and Prospect (2014-2025)
1.4.5 China Diffuse Large B Cell Lymphoma Drug Status and Prospect (2014-2025)
1.4.6 Japan Diffuse Large B Cell Lymphoma Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Diffuse Large B Cell Lymphoma Drug Status and Prospect (2014-2025)
1.4.8 India Diffuse Large B Cell Lymphoma Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Diffuse Large B Cell Lymphoma Drug
2.3 Manufacturing Process Analysis of Diffuse Large B Cell Lymphoma Drug
2.4 Industry Chain Structure of Diffuse Large B Cell Lymphoma Drug

3 Development and Manufacturing Plants Analysis of Diffuse Large B Cell Lymphoma Drug
3.1 Capacity and Commercial Production Date
3.2 Global Diffuse Large B Cell Lymphoma Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Diffuse Large B Cell Lymphoma Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Diffuse Large B Cell Lymphoma Drug Production and Capacity Analysis
4.2 Diffuse Large B Cell Lymphoma Drug Revenue Analysis
4.3 Diffuse Large B Cell Lymphoma Drug Price Analysis
4.4 Market Concentration Degree

5 Diffuse Large B Cell Lymphoma Drug Regional Market Analysis
5.1 Diffuse Large B Cell Lymphoma Drug Production by Regions
5.1.1 Global Diffuse Large B Cell Lymphoma Drug Production by Regions
5.1.2 Global Diffuse Large B Cell Lymphoma Drug Revenue by Regions
5.2 Diffuse Large B Cell Lymphoma Drug Consumption by Regions
5.3 North America Diffuse Large B Cell Lymphoma Drug Market Analysis
5.3.1 North America Diffuse Large B Cell Lymphoma Drug Production
5.3.2 North America Diffuse Large B Cell Lymphoma Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Diffuse Large B Cell Lymphoma Drug Import and Export
5.4 Europe Diffuse Large B Cell Lymphoma Drug Market Analysis
5.4.1 Europe Diffuse Large B Cell Lymphoma Drug Production
5.4.2 Europe Diffuse Large B Cell Lymphoma Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Diffuse Large B Cell Lymphoma Drug Import and Export
5.5 China Diffuse Large B Cell Lymphoma Drug Market Analysis
5.5.1 China Diffuse Large B Cell Lymphoma Drug Production
5.5.2 China Diffuse Large B Cell Lymphoma Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Diffuse Large B Cell Lymphoma Drug Import and Export
5.6 Japan Diffuse Large B Cell Lymphoma Drug Market Analysis
5.6.1 Japan Diffuse Large B Cell Lymphoma Drug Production
5.6.2 Japan Diffuse Large B Cell Lymphoma Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Diffuse Large B Cell Lymphoma Drug Import and Export
5.7 Southeast Asia Diffuse Large B Cell Lymphoma Drug Market Analysis
5.7.1 Southeast Asia Diffuse Large B Cell Lymphoma Drug Production
5.7.2 Southeast Asia Diffuse Large B Cell Lymphoma Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Diffuse Large B Cell Lymphoma Drug Import and Export
5.8 India Diffuse Large B Cell Lymphoma Drug Market Analysis
5.8.1 India Diffuse Large B Cell Lymphoma Drug Production
5.8.2 India Diffuse Large B Cell Lymphoma Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Diffuse Large B Cell Lymphoma Drug Import and Export

6 Diffuse Large B Cell Lymphoma Drug Segment Market Analysis (by Type)
6.1 Global Diffuse Large B Cell Lymphoma Drug Production by Type
6.2 Global Diffuse Large B Cell Lymphoma Drug Revenue by Type
6.3 Diffuse Large B Cell Lymphoma Drug Price by Type

7 Diffuse Large B Cell Lymphoma Drug Segment Market Analysis (by Application)
7.1 Global Diffuse Large B Cell Lymphoma Drug Consumption by Application
7.2 Global Diffuse Large B Cell Lymphoma Drug Consumption Market Share by Application (2014-2019)

8 Diffuse Large B Cell Lymphoma Drug Major Manufacturers Analysis
8.1 AbbVie
8.1.1 AbbVie Diffuse Large B Cell Lymphoma Drug Production Sites and Area Served
8.1.2 AbbVie Product Introduction, Application and Specification
8.1.3 AbbVie Diffuse Large B Cell Lymphoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Arrien Pharmaceuticals
8.2.1 Arrien Pharmaceuticals Diffuse Large B Cell Lymphoma Drug Production Sites and Area Served
8.2.2 Arrien Pharmaceuticals Product Introduction, Application and Specification
8.2.3 Arrien Pharmaceuticals Diffuse Large B Cell Lymphoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Aptose Biosciences
8.3.1 Aptose Biosciences Diffuse Large B Cell Lymphoma Drug Production Sites and Area Served
8.3.2 Aptose Biosciences Product Introduction, Application and Specification
8.3.3 Aptose Biosciences Diffuse Large B Cell Lymphoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 BeiGene
8.4.1 BeiGene Diffuse Large B Cell Lymphoma Drug Production Sites and Area Served
8.4.2 BeiGene Product Introduction, Application and Specification
8.4.3 BeiGene Diffuse Large B Cell Lymphoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Celltrion
8.5.1 Celltrion Diffuse Large B Cell Lymphoma Drug Production Sites and Area Served
8.5.2 Celltrion Product Introduction, Application and Specification
8.5.3 Celltrion Diffuse Large B Cell Lymphoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 CTI BioPharma
8.6.1 CTI BioPharma Diffuse Large B Cell Lymphoma Drug Production Sites and Area Served
8.6.2 CTI BioPharma Product Introduction, Application and Specification
8.6.3 CTI BioPharma Diffuse Large B Cell Lymphoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Erytech Pharma
8.7.1 Erytech Pharma Diffuse Large B Cell Lymphoma Drug Production Sites and Area Served
8.7.2 Erytech Pharma Product Introduction, Application and Specification
8.7.3 Erytech Pharma Diffuse Large B Cell Lymphoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Hetero Drugs
8.8.1 Hetero Drugs Diffuse Large B Cell Lymphoma Drug Production Sites and Area Served
8.8.2 Hetero Drugs Product Introduction, Application and Specification
8.8.3 Hetero Drugs Diffuse Large B Cell Lymphoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Karyopharm Therapeutics
8.9.1 Karyopharm Therapeutics Diffuse Large B Cell Lymphoma Drug Production Sites and Area Served
8.9.2 Karyopharm Therapeutics Product Introduction, Application and Specification
8.9.3 Karyopharm Therapeutics Diffuse Large B Cell Lymphoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 mAbxience
8.10.1 mAbxience Diffuse Large B Cell Lymphoma Drug Production Sites and Area Served
8.10.2 mAbxience Product Introduction, Application and Specification
8.10.3 mAbxience Diffuse Large B Cell Lymphoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 PIQUR Therapeutics
8.12 Philogen S.p.A.
8.13 Roche
8.14 Seattle Genetics
8.15 TG Therapeutics

9 Development Trend of Analysis of Diffuse Large B Cell Lymphoma Drug Market
9.1 Global Diffuse Large B Cell Lymphoma Drug Market Trend Analysis
9.1.1 Global Diffuse Large B Cell Lymphoma Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Diffuse Large B Cell Lymphoma Drug Regional Market Trend
9.2.1 North America Diffuse Large B Cell Lymphoma Drug Forecast 2019-2025
9.2.2 Europe Diffuse Large B Cell Lymphoma Drug Forecast 2019-2025
9.2.3 China Diffuse Large B Cell Lymphoma Drug Forecast 2019-2025
9.2.4 Japan Diffuse Large B Cell Lymphoma Drug Forecast 2019-2025
9.2.5 Southeast Asia Diffuse Large B Cell Lymphoma Drug Forecast 2019-2025
9.2.6 India Diffuse Large B Cell Lymphoma Drug Forecast 2019-2025
9.3 Diffuse Large B Cell Lymphoma Drug Market Trend (Product Type)
9.4 Diffuse Large B Cell Lymphoma Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Diffuse Large B Cell Lymphoma Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Diffuse Large B Cell Lymphoma Drug
Table Global Diffuse Large B Cell Lymphoma Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Diffuse Large B Cell Lymphoma Drug Production Market Share by Types in 2018
Figure Rituxan Product Picture
Figure Cyclophosphamide Product Picture
Figure Doxorubicin Product Picture
Figure Vincristine Product Picture
Figure Prednisone Product Picture
Table Global Diffuse Large B Cell Lymphoma Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Diffuse Large B Cell Lymphoma Drug Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Others
Figure Global Diffuse Large B Cell Lymphoma Drug Revenue (Million USD) (2014-2025)
Figure Global Diffuse Large B Cell Lymphoma Drug Production (K Pcs) (2014-2025)
Figure North America Diffuse Large B Cell Lymphoma Drug Market Size (Million USD) (2014-2025)
Figure Europe Diffuse Large B Cell Lymphoma Drug Market Size (Million USD) (2014-2025)
Figure China Diffuse Large B Cell Lymphoma Drug Market Size (Million USD) (2014-2025)
Figure Japan Diffuse Large B Cell Lymphoma Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Diffuse Large B Cell Lymphoma Drug Market Size (Million USD) (2014-2025)
Figure India Diffuse Large B Cell Lymphoma Drug Market Size (Million USD) (2014-2025)
Table Diffuse Large B Cell Lymphoma Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Diffuse Large B Cell Lymphoma Drug in 2018
Figure Manufacturing Process Analysis of Diffuse Large B Cell Lymphoma Drug
Figure Industry Chain Structure of Diffuse Large B Cell Lymphoma Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Diffuse Large B Cell Lymphoma Drug Manufacturing Plants Distribution
Table Diffuse Large B Cell Lymphoma Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Diffuse Large B Cell Lymphoma Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Diffuse Large B Cell Lymphoma Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Diffuse Large B Cell Lymphoma Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Diffuse Large B Cell Lymphoma Drug Production Share by Manufacturers in 2018
Table Diffuse Large B Cell Lymphoma Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Diffuse Large B Cell Lymphoma Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Diffuse Large B Cell Lymphoma Drug Revenue Share by Manufacturers in 2018
Table Diffuse Large B Cell Lymphoma Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Diffuse Large B Cell Lymphoma Drug Production by Regions 2014-2019 (K Pcs)
Table Global Diffuse Large B Cell Lymphoma Drug Production Market Share by Regions 2014-2019
Figure Global Diffuse Large B Cell Lymphoma Drug Production Market Share by Regions in 2018
Table Global Diffuse Large B Cell Lymphoma Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Diffuse Large B Cell Lymphoma Drug Revenue Market Share by Regions 2014-2019
Figure Global Diffuse Large B Cell Lymphoma Drug Revenue Market Share by Regions in 2018
Table Global Diffuse Large B Cell Lymphoma Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Diffuse Large B Cell Lymphoma Drug Consumption Market Share by Regions 2014-2019
Figure North America Diffuse Large B Cell Lymphoma Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Diffuse Large B Cell Lymphoma Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Diffuse Large B Cell Lymphoma Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Diffuse Large B Cell Lymphoma Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Diffuse Large B Cell Lymphoma Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Diffuse Large B Cell Lymphoma Drug Production, Consumption Import and Export (K Pcs)
Figure China Diffuse Large B Cell Lymphoma Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Diffuse Large B Cell Lymphoma Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Diffuse Large B Cell Lymphoma Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Diffuse Large B Cell Lymphoma Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Diffuse Large B Cell Lymphoma Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Diffuse Large B Cell Lymphoma Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Diffuse Large B Cell Lymphoma Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Diffuse Large B Cell Lymphoma Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Diffuse Large B Cell Lymphoma Drug Production, Consumption Import and Export (K Pcs)
Figure India Diffuse Large B Cell Lymphoma Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Diffuse Large B Cell Lymphoma Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Diffuse Large B Cell Lymphoma Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Diffuse Large B Cell Lymphoma Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Diffuse Large B Cell Lymphoma Drug Market Share by Application (2014-2019)
Table AbbVie Diffuse Large B Cell Lymphoma Drug Production Sites and Area Served
Table AbbVie Diffuse Large B Cell Lymphoma Drug Product Introduction, Application and Specification
Table AbbVie Diffuse Large B Cell Lymphoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table AbbVie Diffuse Large B Cell Lymphoma Drug Production Growth Rate (2014-2019)
Table AbbVie Diffuse Large B Cell Lymphoma Drug Production Market Share (2014-2019)
Figure AbbVie Diffuse Large B Cell Lymphoma Drug Revenue Market Share (2014-2019)
Table AbbVie Diffuse Large B Cell Lymphoma Drug Main Business and Markets Served
Table Arrien Pharmaceuticals Diffuse Large B Cell Lymphoma Drug Production Sites and Area Served
Table Arrien Pharmaceuticals Diffuse Large B Cell Lymphoma Drug Product Introduction, Application and Specification
Table Arrien Pharmaceuticals Diffuse Large B Cell Lymphoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Arrien Pharmaceuticals Diffuse Large B Cell Lymphoma Drug Production Growth Rate (2014-2019)
Table Arrien Pharmaceuticals Diffuse Large B Cell Lymphoma Drug Production Market Share (2014-2019)
Figure Arrien Pharmaceuticals Diffuse Large B Cell Lymphoma Drug Revenue Market Share (2014-2019)
Table Arrien Pharmaceuticals Diffuse Large B Cell Lymphoma Drug Main Business and Markets Served
Table Aptose Biosciences Diffuse Large B Cell Lymphoma Drug Production Sites and Area Served
Table Aptose Biosciences Diffuse Large B Cell Lymphoma Drug Product Introduction, Application and Specification
Table Aptose Biosciences Diffuse Large B Cell Lymphoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Aptose Biosciences Diffuse Large B Cell Lymphoma Drug Production Growth Rate (2014-2019)
Table Aptose Biosciences Diffuse Large B Cell Lymphoma Drug Production Market Share (2014-2019)
Figure Aptose Biosciences Diffuse Large B Cell Lymphoma Drug Revenue Market Share (2014-2019)
Table Aptose Biosciences Diffuse Large B Cell Lymphoma Drug Main Business and Markets Served
Table BeiGene Diffuse Large B Cell Lymphoma Drug Production Sites and Area Served
Table BeiGene Diffuse Large B Cell Lymphoma Drug Product Introduction, Application and Specification
Table BeiGene Diffuse Large B Cell Lymphoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table BeiGene Diffuse Large B Cell Lymphoma Drug Production Growth Rate (2014-2019)
Table BeiGene Diffuse Large B Cell Lymphoma Drug Production Market Share (2014-2019)
Figure BeiGene Diffuse Large B Cell Lymphoma Drug Revenue Market Share (2014-2019)
Table BeiGene Diffuse Large B Cell Lymphoma Drug Main Business and Markets Served
Table Celltrion Diffuse Large B Cell Lymphoma Drug Production Sites and Area Served
Table Celltrion Diffuse Large B Cell Lymphoma Drug Product Introduction, Application and Specification
Table Celltrion Diffuse Large B Cell Lymphoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Celltrion Diffuse Large B Cell Lymphoma Drug Production Growth Rate (2014-2019)
Table Celltrion Diffuse Large B Cell Lymphoma Drug Production Market Share (2014-2019)
Figure Celltrion Diffuse Large B Cell Lymphoma Drug Revenue Market Share (2014-2019)
Table Celltrion Diffuse Large B Cell Lymphoma Drug Main Business and Markets Served
Table CTI BioPharma Diffuse Large B Cell Lymphoma Drug Production Sites and Area Served
Table CTI BioPharma Diffuse Large B Cell Lymphoma Drug Product Introduction, Application and Specification
Table CTI BioPharma Diffuse Large B Cell Lymphoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table CTI BioPharma Diffuse Large B Cell Lymphoma Drug Production Growth Rate (2014-2019)
Table CTI BioPharma Diffuse Large B Cell Lymphoma Drug Production Market Share (2014-2019)
Figure CTI BioPharma Diffuse Large B Cell Lymphoma Drug Revenue Market Share (2014-2019)
Table CTI BioPharma Diffuse Large B Cell Lymphoma Drug Main Business and Markets Served
Table Erytech Pharma Diffuse Large B Cell Lymphoma Drug Production Sites and Area Served
Table Erytech Pharma Diffuse Large B Cell Lymphoma Drug Product Introduction, Application and Specification
Table Erytech Pharma Diffuse Large B Cell Lymphoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Erytech Pharma Diffuse Large B Cell Lymphoma Drug Production Growth Rate (2014-2019)
Table Erytech Pharma Diffuse Large B Cell Lymphoma Drug Production Market Share (2014-2019)
Figure Erytech Pharma Diffuse Large B Cell Lymphoma Drug Revenue Market Share (2014-2019)
Table Erytech Pharma Diffuse Large B Cell Lymphoma Drug Main Business and Markets Served
Table Hetero Drugs Diffuse Large B Cell Lymphoma Drug Production Sites and Area Served
Table Hetero Drugs Diffuse Large B Cell Lymphoma Drug Product Introduction, Application and Specification
Table Hetero Drugs Diffuse Large B Cell Lymphoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Hetero Drugs Diffuse Large B Cell Lymphoma Drug Production Growth Rate (2014-2019)
Table Hetero Drugs Diffuse Large B Cell Lymphoma Drug Production Market Share (2014-2019)
Figure Hetero Drugs Diffuse Large B Cell Lymphoma Drug Revenue Market Share (2014-2019)
Table Hetero Drugs Diffuse Large B Cell Lymphoma Drug Main Business and Markets Served
Table Karyopharm Therapeutics Diffuse Large B Cell Lymphoma Drug Production Sites and Area Served
Table Karyopharm Therapeutics Diffuse Large B Cell Lymphoma Drug Product Introduction, Application and Specification
Table Karyopharm Therapeutics Diffuse Large B Cell Lymphoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Karyopharm Therapeutics Diffuse Large B Cell Lymphoma Drug Production Growth Rate (2014-2019)
Table Karyopharm Therapeutics Diffuse Large B Cell Lymphoma Drug Production Market Share (2014-2019)
Figure Karyopharm Therapeutics Diffuse Large B Cell Lymphoma Drug Revenue Market Share (2014-2019)
Table Karyopharm Therapeutics Diffuse Large B Cell Lymphoma Drug Main Business and Markets Served
Table mAbxience Diffuse Large B Cell Lymphoma Drug Production Sites and Area Served
Table mAbxience Diffuse Large B Cell Lymphoma Drug Product Introduction, Application and Specification
Table mAbxience Diffuse Large B Cell Lymphoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table mAbxience Diffuse Large B Cell Lymphoma Drug Production Growth Rate (2014-2019)
Table mAbxience Diffuse Large B Cell Lymphoma Drug Production Market Share (2014-2019)
Figure mAbxience Diffuse Large B Cell Lymphoma Drug Revenue Market Share (2014-2019)
Table mAbxience Diffuse Large B Cell Lymphoma Drug Main Business and Markets Served
Table PIQUR Therapeutics Diffuse Large B Cell Lymphoma Drug Production Sites and Area Served
Table Philogen S.p.A. Diffuse Large B Cell Lymphoma Drug Production Sites and Area Served
Table Roche Diffuse Large B Cell Lymphoma Drug Production Sites and Area Served
Table Seattle Genetics Diffuse Large B Cell Lymphoma Drug Production Sites and Area Served
Table TG Therapeutics Diffuse Large B Cell Lymphoma Drug Production Sites and Area Served
Figure Global Diffuse Large B Cell Lymphoma Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Diffuse Large B Cell Lymphoma Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Diffuse Large B Cell Lymphoma Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Diffuse Large B Cell Lymphoma Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Diffuse Large B Cell Lymphoma Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Diffuse Large B Cell Lymphoma Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Diffuse Large B Cell Lymphoma Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Diffuse Large B Cell Lymphoma Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Diffuse Large B Cell Lymphoma Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Diffuse Large B Cell Lymphoma Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Diffuse Large B Cell Lymphoma Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Diffuse Large B Cell Lymphoma Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Diffuse Large B Cell Lymphoma Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Diffuse Large B Cell Lymphoma Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Diffuse Large B Cell Lymphoma Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Diffuse Large B Cell Lymphoma Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Diffuse Large B Cell Lymphoma Drug by Application (2019-2025)
Table Diffuse Large B Cell Lymphoma Drug Distributors List
Table Diffuse Large B Cell Lymphoma Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

AbbVie、Arrien Pharmaceuticals、Aptose Biosciences、BeiGene、Celltrion、CTI BioPharma、Erytech Pharma、Hetero Drugs、Karyopharm Therapeutics、mAbxience、PIQUR Therapeutics、Philogen S.p.A.、Roche、Seattle Genetics、TG Therapeutics、

★調査レポート[世界のびまん性大細胞型B細胞リンパ腫薬市場 2019年] (コード：DATA909X06476)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のびまん性大細胞型B細胞リンパ腫薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • BCL-2（B細胞リンパ腫2）阻害剤の世界市場：規模・現状・予測2019-2025
    DATA909X18213 / QYResearch / 2019年11月25日 / ※当調査レポートでは、BCL-2（B細胞リンパ腫2）阻害剤の世界市場について調査・分析し、BCL-2（B細胞リンパ腫2）阻害剤の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（併用療法、単剤療法）、用途別（陽性リンパ腫、濾胞性リンパ腫、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のBCL-2（B細胞リンパ腫2）阻害剤市場動向 ・主要企業別マーケットシェア ・BCL-2（B細胞リンパ腫2）阻害剤の種類別市場規模2014-2019 （併用療法、単剤療法） ・BCL-2（B細胞リンパ腫2）阻害剤の用途別市場規模2014-2019 （陽性リンパ腫、濾胞性リンパ腫、その他） ・BCL-2（B細胞リンパ腫2）阻害剤の北米市場：主要企業・種類別/用途別市場規模 ・BCL-2（B細胞リンパ腫2）阻害剤のヨーロッパ市場：主要企業・種類別/用途別市場規模...Symptoms of hematologic malignancies are usually mild or inconspicuous, leading to delays in diagnosis and treatment of indications.BCL-2 (B-cell lymphoma 2) inhibitors  regulates the correlation of cell apoptosis at the mitochondrial level, which has the potential to be a therapeutic target for hematologic malignancies.In 2018, the global BCL-2 (B-cell lymphoma 2) Inhibitors market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global BCL-2 (B-cell lymphoma 2) Inhibitors status, future forecast, growth opportunity, key market and key players....
  • B細胞リンパ腫2阻害剤の世界市場：規模・現状・予測2019-2025
    DATA909X18212 / QYResearch / 2019年11月25日 / ※当調査レポートでは、B細胞リンパ腫2阻害剤の世界市場について調査・分析し、B細胞リンパ腫2阻害剤の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（併用療法、単剤療法）、用途別（慢性リンパ性白血病、小リンパ球性リンパ腫、急性骨髄性白血病）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のB細胞リンパ腫2阻害剤市場動向 ・主要企業別マーケットシェア ・B細胞リンパ腫2阻害剤の種類別市場規模2014-2019 （併用療法、単剤療法） ・B細胞リンパ腫2阻害剤の用途別市場規模2014-2019 （慢性リンパ性白血病、小リンパ球性リンパ腫、急性骨髄性白血病） ・B細胞リンパ腫2阻害剤の北米市場：主要企業・種類別/用途別市場規模 ・B細胞リンパ腫2阻害剤のヨーロッパ市場：主要企業・種類別/用途別市場規模...Bcl-2 (B-cell lymphoma 2), encoded in humans by the BCL2 gene, is the founding member of the Bcl-2 family of regulator proteins that regulate cell death (apoptosis), by either inhibiting (anti-apoptotic) or inducing (pro-apoptotic) apoptosis.The symptoms of hematological malignancies are often mild or not apparent, which delays diagnosis and treatment. To overcome this challenge, many organizations such as KNOW AML group and market vendors have been organizing awareness campaigns, which educate patients about the symptoms and available diagnostic methods and treatment options. This factor has increased the sales of various therapeutics, including BCL-2 inhibitors, which is a crucial drug for...
  • マントル細胞リンパ腫治療法の世界市場：規模・現状・予測2019-2025
    DATA909X18670 / QYResearch / 2019年11月25日 / ※当調査レポートでは、マントル細胞リンパ腫治療法の世界市場について調査・分析し、マントル細胞リンパ腫治療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（併用療法、単剤療法）、用途別（病院、研究所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のマントル細胞リンパ腫治療法市場動向 ・主要企業別マーケットシェア ・マントル細胞リンパ腫治療法の種類別市場規模2014-2019 （併用療法、単剤療法） ・マントル細胞リンパ腫治療法の用途別市場規模2014-2019 （病院、研究所、その他） ・マントル細胞リンパ腫治療法の北米市場：主要企業・種類別/用途別市場規模 ・マントル細胞リンパ腫治療法のヨーロッパ市場：主要企業・種類別/用途別市場規模...Mantle cell lymphoma (MCL) is a heterogeneous aggressive disease and remains incurable with current chemotherapies. The development of monoclonal antibody (mAb) has led to substantial achievement in immunotherapeutic strategies for B-cell lymphomas including MCL.Nonetheless, progress in the clinical use of mAbs is hindered by poor efficacy, off-target toxicities and drug resistance. Thus, novel mAbs engineering and approaches to improve target specificity and enhance affinity and potency are required. In 2018, the global Mantle Cell Lymphoma Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of...
  • 世界のホジキンリンパ腫治療市場 2019年
    DATA909X09212 / QYResearch / 2019年11月20日 / ※本調査レポートは、ホジキンリンパ腫治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、Alocrest、ANKプログラム、Azacitidine、BMS-986016、BPX-501、その他に、用途別には、病院、診療所、研究センターにセグメント区分し、ホジキンリンパ腫治療の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ホジキンリンパ腫治療の世界市場概要 ・ホジキンリンパ腫治療の製造コスト構成分析 ・ホジキンリンパ腫治療の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ホジキンリンパ腫治療の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ホジキンリンパ腫治療のセグメント分析（種類別） （Alocrest、ANKプログラム、Azacitidine、BMS-986016、BPX-501、その他）...The global Hodgkin Lymphoma Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hodgkin Lymphoma Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hodgkin Lymphoma Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Hodgkin Lymphoma Treatment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の鎌状赤血球症薬市場 2019年
    DATA909X15027 / QYResearch / 2019年11月20日 / ※本調査レポートは、鎌状赤血球症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ARQ-092、BIVV-003、CAL-H、CTX-001、DRX-194、その他に、用途別には、病院、診療所、その他にセグメント区分し、鎌状赤血球症薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・鎌状赤血球症薬の世界市場概要 ・鎌状赤血球症薬の製造コスト構成分析 ・鎌状赤血球症薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・鎌状赤血球症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・鎌状赤血球症薬のセグメント分析（種類別） （ARQ-092、BIVV-003、CAL-H、CTX-001、DRX-194、その他）...The global Sickle Cell Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Sickle Cell Disease Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Sickle Cell Disease Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Sickle Cell Disease Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界のバーキットリンパ腫の治療市場 2019年
    DATA909X04887 / QYResearch / 2019年11月15日 / ※本調査レポートは、バーキットリンパ腫の治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ARV-825、アリセルチブ、bb-2121、イブルチニブ、その他に、用途別には、病院、診療所、その他にセグメント区分し、バーキットリンパ腫の治療の世界市場を分析しました。 ・エグゼクティブ・サマリー ・バーキットリンパ腫の治療の世界市場概要 ・バーキットリンパ腫の治療の製造コスト構成分析 ・バーキットリンパ腫の治療の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・バーキットリンパ腫の治療の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・バーキットリンパ腫の治療のセグメント分析（種類別） （ARV-825、アリセルチブ、bb-2121、イブルチニブ、その他）...The global Burkitt Lymphoma Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Burkitt Lymphoma Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Burkitt Lymphoma Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Burkitt Lymphoma Treatment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の平滑筋肉腫薬市場 2019年
    DATA909X10490 / QYResearch / 2019年11月20日 / ※本調査レポートは、平滑筋肉腫薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、AL-3818、BGB-290、C-21、その他に、用途別には、クリニック、病院、その他にセグメント区分し、平滑筋肉腫薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・平滑筋肉腫薬の世界市場概要 ・平滑筋肉腫薬の製造コスト構成分析 ・平滑筋肉腫薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・平滑筋肉腫薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・平滑筋肉腫薬のセグメント分析（種類別） （AL-3818、BGB-290、C-21、その他）...The global Leiomyosarcoma Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Leiomyosarcoma Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Leiomyosarcoma Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Leiomyosarcoma Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Leiomyosarcoma Drug manufacturing...

    • ◆H&Iグローバルリサーチのお客様（例）◆